Evidence map›Paper›PMID 29196878›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Gut microbiome production of short-chain fatty acids and obesity in children.

Selvasankar Murugesan, Khemlal Nirmalkar, Carlos Hoyo-Vadillo, Matilde García-Espitia, Daniela Ramírez-Sánchez, Jaime García-Mena

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 5 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 5 syntheses or guidelines pooled it, 222 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Selvasankar MurugesanDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Zacatenco, Av. Instituto Politécnico Nacional 2508, 07360, Ciudad de México, Mexico.
Khemlal NirmalkarDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Zacatenco, Av. Instituto Politécnico Nacional 2508, 07360, Ciudad de México, Mexico.
Carlos Hoyo-VadilloDepartamento de Farmacología, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Zacatenco, Av. Instituto Politécnico Nacional 2508, 07360, Ciudad de México, Mexico.
Matilde García-EspitiaEscuela Nacional de Medicina y Homeopatía del IPN, Guillermo Massieu Helguera 239, 07320, México DF, Mexico.
Daniela Ramírez-SánchezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Zacatenco, Av. Instituto Politécnico Nacional 2508, 07360, Ciudad de México, Mexico.
Jaime García-MenaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Zacatenco, Av. Instituto Politécnico Nacional 2508, 07360, Ciudad de México, Mexico. jgmena@cinvestav.mx.ORCID http://orcid.org/0000-0002-0595-3711
Instituto Politécnico Nacional · MX

Funding

Consejo Nacional de Ciencia y Tecnología FONSEC SS/IMSS/ISSSTE-CONACYT-233361Consejo Nacional de Ciencia y Tecnología (MX) CONACyT 163235 INFR-2011-01Fundación Miguel Alemán A C 2015
6 · The paper itself

Abstract

Obesity has been a worldwide multifactorial epidemic malady for the last 2 decades. Changes in gut microbiota composition and its metabolites - short-chain fatty acids (SCFAs) - have been associated with obesity. Recent evidence suggests that SCFAs made by the gut microbiota may regulate directly or indirectly physiological and pathological processes in relation to obesity. We review the influence of gut microbiota in energy, glucose, and lipid homeostasis control via their metabolites. Gut microbial disturbances in obese children may have a role in their metabolism. At first glance, excessive short-chain fatty acids produced by a particular gut microbiota represent an additional energy source, and should cause an imbalance in energy regulation, contributing to obesity. However, simultaneously, SCFA participates in glucose-stimulated insulin secretion from the pancreatic β-cells through interaction with the FFA2 and FFA3 receptors, and release of peptide hormones which control appetite. This apparent contradictory situation may indicate the involvement of additional particular bacteria or bacterial components or metabolites that may trigger regulatory cascades by interaction with some G-protein-coupled membrane receptors.

Indexed as

Fatty Acids, VolatileGastrointestinal MicrobiomePediatric ObesityAdolescentChildHumansMetabolomeFatty Acids, Volatile

Identifiers

PMID29196878
OpenAlexW2774633776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.